Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

JEHSX vs. QAAGZX: which is better?

Bottom line

JEHSX vs QAAGZX: the short answer

JEHSX (Health Sciences Trust) and QAAGZX (T. Rowe Price Health Sciences Portfolio) have nearly the same top holdings — their top 25 positions are about 96% the same by weight.

QAAGZX is cheaper at 0.86% vs 1.04% — a difference of $18 a year per $10,000 invested.

Over five years, JEHSX returned +4.2% a year vs +4.1% for QAAGZX.

Updated Nov 19, 2026

JEHSX vs QAAGZX side by side

JEHSXQAAGZX
TypeMutual fundETF
Fund familyJohn HancockT. Rowe Price
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.04%0.86%
Annual cost per $10k$104$86
10-yr cost on $10k (prospectus)$1,282$1,061
Max front load—None
12b-1 fee0.05%0%
1-yr return+19.5%+18.1%
5-yr return (annualized)+4.2%+4.1%
10-yr return (annualized)+8.7%+9.0%
Best quarter+23.6%+23.4%
Worst quarter−16.1%−15.8%
Net assets (fund)$251.3M$751.7M
Number of holdings173277
Portfolio turnover68%65%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearJEHSXQAAGZXDifference
2025+19.5%+18.1%+1.4%
2024+1.8%+1.7%+0.1%
2023+4.3%+3.0%+1.3%
2022−13.1%−12.5%−0.6%
2021+11.2%+13.1%−1.9%
2020+27.2%+29.6%−2.5%
2019+28.7%+29.0%−0.3%
2018+0.7%+1.1%−0.4%
2017+27.5%+27.6%−0.1%
2016−10.6%−10.5%−0.1%

Source: Fund prospectus bar charts

Holdings overlap

23 of JEHSX's top 25 holdings also appear in QAAGZX's top 25.

Shared top holdings
HoldingJEHSXQAAGZX
Eli Lilly and Company14.30%14.06%
Johnson and Johnson6.33%6.64%
UnitedHealth Group Incorporated5.95%5.88%
AbbVie Inc.5.28%5.12%
Merck and Co. Inc.4.21%4.00%
Gilead Sciences Inc.2.95%2.79%
Thermo Fisher Scientific Inc.2.67%2.53%
Vertex Pharmaceuticals Incorporated2.38%2.26%
Bristol-Myers Squibb Company2.22%2.12%
Abbott Laboratories2.00%1.91%
Intuitive Surgical Inc.1.98%1.89%
Amgen Inc.1.90%1.80%
Stryker Corporation1.87%1.78%
Elevance Health Inc.1.63%1.54%
Danaher Corporation1.51%1.44%

Source: SEC Form N-PORT

JEHSX top 10

  1. Eli Lilly and Company — 14.30%
  2. Johnson and Johnson — 6.33%
  3. UnitedHealth Group Incorporated — 5.95%
  4. AbbVie Inc. — 5.28%
  5. Merck and Co. Inc. — 4.21%
  6. Gilead Sciences Inc. — 2.95%
  7. Thermo Fisher Scientific Inc. — 2.67%
  8. Vertex Pharmaceuticals Incorporated — 2.38%
  9. Bristol-Myers Squibb Company — 2.22%
  10. Abbott Laboratories — 2.00%

QAAGZX top 10

  1. Eli Lilly & Co — 14.06%
  2. Johnson & Johnson — 6.64%
  3. Unitedhealth Group Inc — 5.88%
  4. Abbvie Inc — 5.12%
  5. Merck & Co. Inc. — 4.00%
  6. Gilead Sciences Inc — 2.79%
  7. Thermo Fisher Scientific Inc — 2.53%
  8. Vertex Pharmaceuticals Inc — 2.26%
  9. Bristol-myers Squibb Co — 2.12%
  10. Abbott Laboratories — 1.91%

FAQ

What is the difference between JEHSX and QAAGZX?
JEHSX (Health Sciences Trust) and QAAGZX (T. Rowe Price Health Sciences Portfolio) have nearly the same top holdings — their top 25 positions are about 96% the same by weight. QAAGZX is cheaper at 0.86% vs 1.04% — a difference of $18 a year per $10,000 invested.
Which is cheaper, JEHSX or QAAGZX?
QAAGZX has the lower expense ratio (0.86%).
Should I own both JEHSX and QAAGZX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.